Search

Your search keyword '"Clusmann, H."' showing total 496 results

Search Constraints

Start Over You searched for: Author "Clusmann, H." Remove constraint Author: "Clusmann, H."
496 results on '"Clusmann, H."'

Search Results

451. Present practice and perspective of evaluation and surgery for temporal lobe epilepsy.

452. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort.

453. Correlation of health-related quality of life after surgery for mesial temporal lobe epilepsy with two seizure outcome scales.

454. Postsurgical outcome in pediatric patients with epilepsy: a comparison of patients with intellectual disabilities, subaverage intelligence, and average-range intelligence.

455. Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach.

456. Processing of famous faces and medial temporal lobe event-related potentials: a depth electrode study.

457. Calbindin-D28k content and firing pattern of hippocampal granule cells in amygdala-kindled rats: a perforated patch-clamp study.

458. Lesional mesial temporal lobe epilepsy and limited resections: prognostic factors and outcome.

459. Rate of vasospasm following the transsylvian versus transcortical approach for selective amygdalohippocampectomy.

460. Neuropsychological outcome after selective amygdalohippocampectomy with transsylvian versus transcortical approach: a randomized prospective clinical trial of surgery for temporal lobe epilepsy.

461. MR imaging in the presurgical workup of patients with drug-resistant epilepsy.

462. Planar brain surface reformations for localization of cortical brain lesions.

463. Steroid sulfatase (STS) expression in the human temporal lobe: enzyme activity, mRNA expression and immunohistochemistry study.

464. Analysis of different types of resection for pediatric patients with temporal lobe epilepsy.

465. Collateral brain damage, a potential source of cognitive impairment after selective surgery for control of mesial temporal lobe epilepsy.

466. Characterization of hemorrhagic complications after surgery for temporal lobe epilepsy.

467. Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.

468. Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy.

469. Down-regulation of mGluR8 in pilocarpine epileptic rats.

470. Outcome of epilepsy surgery in focal cortical dysplasia.

471. Characterization of the dehydroepiandrosterone (DHEA) metabolism via oxysterol 7alpha-hydroxylase and 17-ketosteroid reductase activity in the human brain.

472. Ca2+ entry via P/Q-type Ca2+ channels and the Na+/Ca2+ exchanger in rat and human neocortical synaptosomes.

473. Prognostic factors and outcome after different types of resection for temporal lobe epilepsy.

474. Pre- and postoperative verbal memory in pediatric patients with temporal lobe epilepsy.

475. Improved hybrid clamp: resolution of tail currents following single action potentials.

476. Presynaptic group II metabotropic glutamate receptors reduce stimulated and spontaneous transmitter release in human dentate gyrus.

477. Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery.

478. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.

479. Preoperative evaluation for epilepsy surgery (Bonn Algorithm).

480. Transsylvian keyhole functional hemispherectomy.

481. Postsurgical outcome of children and adolescents with medically refractory frontal lobe epilepsies.

482. Messenger RNA of steroid 21-hydroxylase (CYP21) is expressed in the human hippocampus.

483. Fixed and dilated pupils after trauma, stroke, and previous intracranial surgery: management and outcome.

484. Expression of the 17beta-hydroxysteroid dehydrogenase type 5 mRNA in the human brain.

485. Corticosteroid receptor mRNA expression in the brains of patients with epilepsy.

486. Androgen receptor mRNA expression in the human hippocampus.

487. Analysing metabotropic glutamate group III receptor mediated modulation of synaptic transmission in the amygdala-kindled dentate gyrus of the rat.

488. Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus.

489. Two electrophysiologically distinct types of granule cells in epileptic human hippocampus.

490. Treatment of accidental high dose intraventricular mezlocillin application by cerebrospinal fluid exchange.

491. Metabotropic glutamate receptors modulate synaptic transmission in the perforant path: pharmacology and localization of two distinct receptors.

492. Potassium currents in acutely isolated human hippocampal dentate granule cells.

493. Properties of a delayed rectifier potassium current in dentate granule cells isolated from the hippocampus of patients with chronic temporal lobe epilepsy.

494. Long lasting functional alterations in the rat dentate gyrus following entorhinal cortex lesion: a current source density analysis.

495. Alterations in medial perforant path and mossy fiber induced field potentials in amygdala and beta-carboline (FG 7142) kindled rats.

Catalog

Books, media, physical & digital resources